Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
SciCrunch Registry is a curated repository of scientific resources, with a focus on biomedical resources, including tools, databases, and core facilities - visit SciCrunch to register your resource.
| Resource Name | Proper Citation | Abbreviations | Resource Type |
Description |
Keywords | Resource Relationships | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
pSTIING Resource Report Resource Website 1+ mentions |
pSTIING (RRID:SCR_002045) | pSTIING | data or information resource, database | A publicly accessible knowledgebase about protein-protein, protein-lipid, protein-small molecules, ligand-receptor interactions, receptor-cell type information, transcriptional regulatory and signal transduction modules relevant to inflammation, cell migration and tumourigenesis. It integrates in-house curated information from the literature, biochemical experiments, functional assays and in vivo studies, with publicly available information from multiple and diverse sources across human, rat, mouse, fly, worm and yeast. The knowledgebase allowing users to search and to dynamically generate visual representations of protein-protein interactions and transcriptional regulatory networks. Signalling and transcriptional modules can also be displayed singly or in combination. This allow users to identify important "cross-talks" between signalling modules via connections with key components or "hubs". The knowledgebase will facilitate a "systems-wide" understanding across many protein, signalling and transcriptional regulatory networks triggered by multiple environmental cues, and also serve as a platform for future efforts to computationally and mathematically model the system behavior of inflammatory processes and tumourigenesis. | protein-protein, protein-lipid, protein-small molecule, ligand-receptor interaction, receptor-cell type, transcriptional regulatory module, signal transduction module, inflammation, cell migration, tumorigenesis, protein-protein interaction, transcriptional regulatory network, signalling pathway, interaction, protein interaction, motif, domain, protein, gene |
is listed by: OMICtools is related to: Gene Ontology has parent organization: University College London; London; United Kingdom |
Inflammation, Tumor, Cancer | PMID:16381926 | THIS RESOURCE IS NO LONGER IN SERVICE | OMICS_01916 | SCR_002045 | SciCrunch Registry | Protein Signalling Transcriptional Interactions and Inflammation Networks Gateway, Protein Signalling Transcriptional Interactions & Inflammation Networks Gateway | 2026-10-31 12:19:51 | 2 | |||||
|
Mutation Annotation and Genomic Interpretation Resource Report Resource Website |
Mutation Annotation and Genomic Interpretation (RRID:SCR_002800) | MAGI | analysis service resource, data analysis service, production service resource, service resource | A tool for annotating, exploring, and analyzing gene sets that may be associated with cancer. | mutation, interaction, transcript, copy number aberration, network |
uses: The Cancer Genome Atlas uses: HINT uses: HPRD - Human Protein Reference Database uses: Pfam uses: SMART uses: Conserved Domain Database is listed by: OMICtools has parent organization: Brown University; Rhode Island; USA |
Cancer | NSF ; NIH ; Brown University; Rhode Island; USA |
Free, Freely available, Available for download | OMICS_06145 | SCR_002800 | SciCrunch Registry | MAGI - A tool for Mutation Annotation and Genomic Interpretation | 2026-10-31 12:19:50 | 0 | |||||
|
Arizona Cancer Center Tumor Bank Resource Report Resource Website |
Arizona Cancer Center Tumor Bank (RRID:SCR_003544) | AZCC Tumor Bank | biomaterial supply resource, material resource, tissue bank | TACMASS collects, preserves, and banks biospecimens obtained from Arizona Cancer Center surgical patients who are seen by University Medical Center surgeons and oncologists. Biospecimens collected at the time of surgery include fresh surgical tissue, blood and urine. Serum, plasma and genomic DNA are harvested from the whole blood. AZCC Members and collaborators may request the use of banked biospecimens through TACMASS. The patient's surgeon or oncologist is responsible for consenting the patient for submission of surgical specimens to the AZCC BioRepository (IRB #06-0609-04, Setsuko Chambers, PI). The surgeon and the Department of Pathology attending physicians and residents are responsible for identifying appropriate tissue for banking that will not compromise pathological diagnosis. Tumor and/or normal adjacent tissue, identified by gross examination, that will not be needed for pathological diagnosis are preserved by fixing in formalin, snap freezing, and/or fixing in RNALater. Histological diagnosis is rendered on each piece of formalin-fixed and snap frozen tissue by Hematoxylin and Eosin staining (H&E). Everyone involved in submitting specimens to the Tumor Bank must maintain a current CITI Certification. |
is listed by: One Mind Biospecimen Bank Listing has parent organization: University of Arizona; Arizona; USA |
Cancer, Tumor | nlx_10808 | SCR_003544 | SciCrunch Registry | 2026-10-31 12:19:58 | 0 | |||||||||
|
NetPath Resource Report Resource Website 50+ mentions |
NetPath (RRID:SCR_003567) | NetPath | data or information resource, database | A manually curated resource of signal transduction pathways in humans. All pathways are freely available for download in BioPAX level 3.0, PSI-MI version 2.5 and SBML version 2.1 formats. The slim pathway models representing only core reactions in each pathway are available at NetSlim. All the NetPath pathway models are also submitted to WikiPathways., THIS RESOURCE IS NO LONGER IN SERVICE. Documented on September 16,2025. | pathway, signal transduction, molecule, physical interaction, gene, transcriptional regulation, transport, enzyme catalysis, immune, signaling pathway, FASEB list |
is related to: WikiPathways is related to: ConsensusPathDB has parent organization: Johns Hopkins University; Maryland; USA has parent organization: Institute of Bioinformatics; Bangalore; India |
Cancer | PMID:20067622 | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_157701, r3d100011009 | https://doi.org/10.17616/R34G98 | SCR_003567 | SciCrunch Registry | 2026-10-31 12:20:02 | 91 | |||||
|
Human Tumor Atlas Network Resource Report Resource Website 10+ mentions |
Human Tumor Atlas Network (RRID:SCR_023364) | HTAN | atlas, data or information resource, disease-related portal, portal, topical portal | HTAN is National Cancer Institute funded Cancer Moonshot initiative to construct 3-dimensional atlases of dynamic cellular, morphological, and molecular features of human cancers as they evolve from precancerous lesions to advanced disease.Provides three dimensional atlases of cancer transitions for diverse set of tumor types. Efforts to map healthy organs and previous large-scale cancer genomics approaches focused on bulk sequencing at single point in time. Data portal for Human Tumor Atlas Network. Data available on HTAN Portal is open access. Certain data types with potential for re-identification are available in restricted access through dbGAP. | Three dimensional atlases, cancer transitions, diverse set of tumor types, map healthy organs, cancer genomics approaches, bulk sequencing at single point in time, data, precancerous lesions to advanced disease, | cancer | National Cancer Institut Cancer Moonshot Initiative | PMID:32302568 | Free, Freely available | SCR_023364 | SciCrunch Registry | 2026-10-31 12:18:50 | 42 | |||||||
|
CancerModels.Org Resource Report Resource Website 1+ mentions |
CancerModels.Org (RRID:SCR_023931) | data or information resource, data repository, disease-related portal, portal, service resource, storage service resource, topical portal | Cancer research platform that aggregates clinical, genomic and functional data from various types of patient derived cancer models, xenographs, organoids and cell lines. Open catalog of harmonised patient-derived cancer models. Standardises, harmonises and integrates clinical metadata, molecular and treatment-based data from academic and commercial providers worldwide. Data is FAIR and underpins generation and testing of new hypotheses in cancer mechanisms and personalised medicine development. PDCM Finder have expanded to organoids and cell lines and is now called CancerModels.Org. PDCM Finder was launched in April 2022 as successor of PDX Finder portal, which focused solely on patient-derived xenograft models. | FAIR data, clinical data, genomic data, functional data, patient derived, cancer models, xenographs, organoids, cell lines, | cancer | NCI R01 CA089713; NCI U24 CA204781 01; NCI U24 CA253539 01 |
PMID:36399494 | Free, Freely available | r3d100012961 | https://doi.org/10.17616/R31NJMHT | SCR_023931 | SciCrunch Registry | PDCM Finder, PDX Finder | 2026-10-31 12:18:56 | 8 | |||||
|
Health Information National Trends Survey Resource Report Resource Website 50+ mentions |
Health Information National Trends Survey (RRID:SCR_023943) | HINTS | data or information resource, disease-related portal, portal, topical portal | Regularly collects nationally representative data about American public’s knowledge of, attitudes toward, and use of cancer and health related information. HINTS data are used to monitor changes in fields of health communication and health information technology and to create more effective health communication strategies across different populations. Weighted, nationally representative probability based survey of civilian, non-institutionalized adults administered by National Cancer Institute on knowledge of and attitudes toward cancer relevant information. | National Cancer Institute, HINTS data, American public’s knowledge, cancer relevant information, use of cancer and health related information, survey of civilian and non-institutionalized adults, | cancer | Free, Freely available | SCR_023943 | SciCrunch Registry | Health Information National Trends Survey (HINTS), The Health Information National Trends Survey (HINTS) | 2026-10-31 12:19:01 | 52 | ||||||||
|
Cancer Information Service Resource Report Resource Website 1+ mentions |
Cancer Information Service (RRID:SCR_024445) | data or information resource, disease-related portal, portal, topical portal | Portal provides information on Cancer Statistics in Japan. Official website operated by National Cancer Center for cancer information. | Cancer statistics in Japan, National Cancer Center, cancer information, | cancer | Free, Freely available | SCR_024445 | SciCrunch Registry | Cancer Information Service in Japan | 2026-10-31 12:19:03 | 1 | |||||||||
|
NCI SEER Cancer Statistics Review Resource Report Resource Website 500+ mentions |
NCI SEER Cancer Statistics Review (RRID:SCR_024685) | data or information resource, disease-related portal, portal, topical portal | Platform to report outlining trends in cancer statistics and methods to derive various cancer statistics from the Surveillance, Epidemiology, and End Results (SEER) program. Authoritative source for cancer statistics in the United States. | trends in cancer, cancer statistics, methods to derive various cancer statistics, Surveillance, Epidemiology, and End Results program, SEER program, | cancer | NCI | Free, Freely available | https://seer.cancer.gov/ | SCR_024685 | SciCrunch Registry | SEER Cancer Statistics Review, , National Cancer Institute SEER Cancer Statistics Review, NIH NCI Surveillance, Epidemiology, and End Results Cancer Statistics Review, NIH NCI SEER Cancer Statistics Review | 2026-10-31 12:19:02 | 760 | |||||||
|
Karmanos Cancer Institute Resource Report Resource Website |
Karmanos Cancer Institute (RRID:SCR_000508) | Karmanos | data or information resource, portal | Center for patient care, education and research on cancer. The institute focuses its research on prevention methods, early detection, treatment and finding cures. | cancer, research, education, prevention, early detection, treatment, patient, care |
has parent organization: Wayne State University; Michigan; USA is parent organization of: JP McCarthy Cord Stem Cell Bank |
Cancer | NCI | Public | nlx_143656 | SCR_000508 | SciCrunch Registry | Karmanos Cancer Center, Barbara Ann Karmanos Cancer Institute, Barbara Ann Karmanos Cancer Center | 2026-10-31 12:19:04 | 0 | |||||
|
DCTD Resource Report Resource Website 10+ mentions |
DCTD (RRID:SCR_004196) | DCTD | data or information resource, funding resource, portal | Division of NCI that takes prospective cancer detection and treatment leads, facilitates their paths to clinical application, and expedites the initial and subsequent large-scale testing of new agents, biomarkers, imaging tests, and other therapeutic interventions (radiation, surgery, immunotherapy) in patients. DCTD, like all of NCI, supports many programs that could not be done without government funding - investigators supported by the division engage in scientifically sound, high-risk research that may yield great benefits for patients with cancer, but are too difficult or risky for industry or academia to pursue. This includes a particular emphasis on the development of distinct molecular signatures for cancer, refined molecular assays, and state-of-the-art imaging techniques that will guide oncologic therapy in the future. The division has eight major programs that work together to bring unique molecules, diagnostic tests, and therapeutic interventions from the laboratory bench to the patient bedside: * Cancer Diagnosis Program * Cancer Imaging Program * Cancer Therapy Evaluation Program * Developmental Therapeutics Program * Radiation Research Program * Translational Research Program * Biometrics Research Branch * Office of Cancer Complementary and Alternative Medicine | treatment, diagnosis, molecule, diagnostic test, therapeutic intervention |
is listed by: OMICtools has parent organization: National Cancer Institute is parent organization of: CDP |
Cancer | NCI | OMICS_01537 | SCR_004196 | SciCrunch Registry | Division of Cancer Treatment and Diagnosis | 2026-10-31 12:19:08 | 20 | ||||||
|
Gene Expression Profiling Interactive Analysis Resource Report Resource Website 5000+ mentions |
Gene Expression Profiling Interactive Analysis (RRID:SCR_018294) | GEPIA | analysis service resource, data access protocol, production service resource, service resource, software resource, web service | Web server for cancer and normal gene expression profiling and interactive analyses. Interactive web server for analyzing RNA sequencing expression data of tumors and normal samples from TCGA and GTEx projects, using standard processing pipeline. Provides customizable functions such as tumor or normal differential expression analysis, profiling according to cancer types or pathological stages, patient survival analysis, similar gene detection, correlation analysis and dimensionality reduction analysis. | Cancer gene expression, normal gene expression, analysis, RNA sequencing, expression data, TCGA project, GTEx project, patient survival analysis, correlation analysis |
is related to: Gene Expression Profiling Interactive Analysis 2 has parent organization: Peking University; Beijing; China |
Cancer | National Natural Science Foundation of China ; Peking University |
PMID:28407145 | Free, Freely available | SCR_018294 | SciCrunch Registry | 2026-10-31 12:17:04 | 7126 | ||||||
|
Laser Biomedical Research Center Resource Report Resource Website 1+ mentions |
Laser Biomedical Research Center (RRID:SCR_000106) | LBRC | access service resource, biomedical technology research center, service resource | THIS RESOURCE IS NO LONGER IN SERVICE. Documented on July 31,2025. Biomedical technology research center that develops basic scientific understanding and new techniques required for advancing clinical applications of lasers and spectroscopy. LBRC merges optical spectroscopy, imaging, scattering, and interferometry techniques to study biophysics and biochemistry of healthy and diseased biological structures from subcellular to entire-organ scale. | spectroscopy, laser, biomedicine, optical spectroscopy, imaging, scattering, interferometry, optical probe, microscopy | has parent organization: Massachusetts Institute of Technology; Massachusetts; USA; | Pre-cancer, Cancer, Atherosclerosis, Healthy, Diseased | NIBIB 4P41EB015871-30 | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_152645 | SCR_000106 | SciCrunch Registry | MIT Laser Biomedical Research Center, Laser Biomedical Research Center (LBRC) | 2026-10-31 12:21:50 | 4 | |||||
|
Center for In Vivo Microscopy Resource Report Resource Website 10+ mentions |
Center for In Vivo Microscopy (RRID:SCR_001426) | CIVM | biomedical technology research center, training resource | Biomedical technology research center dedicated to the development of novel imaging methods for the basic scientist and the application of the methods to important biomedical questions. The CIVM has played a major role in the development of magnetic resonance microscopy with specialized MR imaging systems capable of imaging at more than 500,000x higher resolution than is common in the clinical domain. The CIVM was the first to demonstrate MR images using hyperpolarized 3He which has been moved from mouse to man with recent clinical trials performed at Duke in collaboration with GE. More recently the CIVM has developed the molecular imaging workbench---a system dedicated to multimodality cardiopulmonary imaging in the rodent. Their collaborators are employing these unique imaging systems in an extraordinary range of mouse and rat models of neurologic disease, cardiopulmonary disease and cancer to illuminate the underlying biology and explore new therapies. | imaging, magnetic resonance microscopy, magnetic resonance imaging, clinical, mri, ct, x-ray, ultrasound, confocal, optical, spect | has parent organization: Duke University; North Carolina; USA | Cardiopulmonary disease, Cancer, Neurological disease | NIBIB 4P41EB015897-27 | Free, Freely Available | nlx_152650 | SCR_001426 | SciCrunch Registry | Duke Center for In Vivo Microscopy | 2026-10-31 12:22:00 | 10 | |||||
|
Strelka2 Resource Report Resource Website 100+ mentions |
Strelka2 (RRID:SCR_005109) | software resource, source code | Software for somatic single nucleotide variant (SNV) and small indel detection from sequencing data of matched tumor-normal samples. Strelka2 germline and somatic small variant caller. | single nucleotide variant, indel, somatic snv, next-generation sequencing, bio.tools |
is listed by: Debian is listed by: bio.tools is listed by: SoftCite has parent organization: Illumina |
Cancer, Tumor, Normal | PMID:22581179 PMID:30013048 |
Free, Available for download, Freely available | biotools:strelka | https://bio.tools/strelka, https://sources.debian.org/src/strelka/ | http://bioinformatics.oxfordjournals.org/content/early/2012/05/10/bioinformatics.bts271.full.pdf | SCR_005109 | SciCrunch Registry | Strelka | 2026-10-31 12:22:00 | 283 | ||||
|
GSE4922 Resource Report Resource Website 100+ mentions |
GSE4922 (RRID:SCR_003557) | GSE4922 | data or information resource, data set | Curated data set of a study that investigated the expression profiles of 347 primary invasive breast tumors on Affymetrix microarrays. Three separate breast cancer cohorts were analyzed: 1) Uppsala (n=249), 2) Stockholm (n=58), 3) Singapore (n=40). The Uppsala and Singapore data can be accessed in GSE4922. The Stockholm cohort data can be accessed at GEO Series GSE1456. | adult human, expression profile, breast |
is related to: Gene Expression Omnibus has parent organization: RanchoBiosciences |
Cancer, Breast cancer, Tumor | Free, Public | nlx_157796 | SCR_003557 | SciCrunch Registry | 2026-10-31 12:22:01 | 111 | |||||||
|
Herzon Lab Resource Report Resource Website |
Herzon Lab (RRID:SCR_008850) | Herzon Lab | access service resource, core facility, service resource | My laboratory has created a family of natural product-inspired anticancer agents. We have evaluated our compounds at the Yale Center for Chemical Genomics, and they are exhibiting IC50 values in the low nM range against K562, HeLa, LnCAP, and HCT-116 lines. Their mechanism of action is unknown, although the natural products have been shown to cleave DNA. An evaluation of the natural products at the NCI has shown that they have a toxicity profile that is distinct from other known DNA damaging agents. We can readily access gram-quantities of these agents for further studies. We are looking for researchers who might find these compounds useful in medicinal applications, for example, for treatment of a specific cancer. We are capable of synthesizing new analogs, such as those incorporating a specific recognition or targeting element, and would be excited to pursue this avenue of research. | chemistry, synthetic anticancer agent, anticancer agent | has parent organization: Yale University; Connecticut; USA | Cancer | nlx_149076 | SCR_008850 | SciCrunch Registry | Herzon Laboratory | 2026-10-31 12:22:08 | 0 | |||||||
|
TARGETgene Resource Report Resource Website 1+ mentions |
TARGETgene (RRID:SCR_001392) | TARGETgene | software application, software resource | MATLAB tool to effectively identify potential therapeutic targets and drugs in cancer using genetic network-based approaches. It can rapidly extract genetic interactions from a precompiled database stored as a MATLAB MAT-file without the need to interrogate remote SQL databases. Millions of interactions involving thousands of candidate genes can be mapped to the genetic network within minutes. While TARGETgene is currently based on the gene network reported in (Wu et al.,Bioinformatics 26:807-813, 2010), it can be easily extended to allow the optional use of other developed gene networks. The simple graphical user interface also enables rapid, intuitive mapping and analysis of therapeutic targets at the systems level. By mapping predictions to drug-target information, TARGETgene may be used as an initial drug screening tool that identifies compounds for further evaluation. In addition, TARGETgene is expected to be applicable to identify potential therapeutic targets for any type or subtype of cancers, even those rare cancers that are not genetically recognized. Identification of Potential Therapeutic Targets * Prioritize potential therapeutic targets from thousands of candidate genes generated from high-throughput experiments using network-based metrics * Validate predictions (prioritization) using user-defined benchmark genes and curated cancer genes * Explore biologic information of selected targets through external databases (e.g., NCBI Entrez Gene) and gene function enrichment analysis Initial Drug Screening * Identify for further evaluation existing drugs and compounds that may act on the potential therapeutic targets identified by TARGETgene * Explore general information on identified drugs of interest through several external links Operating System: Windows XP / Vista / 7 | disease target, drug discovery, drug, matlab, gene network, genetic interaction, gene, drug screening, mutation driver, therapeutic target, drug candidate, compound, mapping, analysis | has parent organization: Biomedical Simulations Resource | Cancer | NIBIB P41-EB001978 | PMID:22952662 | Free, Under the terms of a Release Agreement., Please cite | nlx_152573 | http://bmsr.usc.edu/Software/TARGET/TARGET.html | SCR_001392 | SciCrunch Registry | 2026-10-31 12:21:04 | 8 | ||||
|
Roswell Park Data Bank and BioRepository Resource Report Resource Website |
Roswell Park Data Bank and BioRepository (RRID:SCR_003607) | DBBR | biomaterial supply resource, material resource | Collects and provides de-identified biospecimens and associated epidemiological and clinical data to meet the scientific needs of investigators. Newly diagnosed patients are asked to contribute data and specimens to the DBBR prior to treatment. Other patients with who have benign disease or advanced disease and have undergone treatment are also enrolled based on anticipated use of data and samples for research. Additionally, non-patients (family members and friends of patients and community members) with no personal history of cancer are asked to participate in the biorepository as controls. Specimens and data are procured with protected health information (PHI) and de-identified prior to distribution to investigators with hypothesis driven IRB reviewed studies. An extensive data collection and management system is in place to track informed consent, questionnaire collection and follow up, epidemiological questionnaire data, clinical data, biospecimens and their derivatives. Research Services * Availability of a bank of prospectively collected blood specimens (serum, plasma, buffy coat, red blood cells and DNA) from cancer patients, high risk individuals and healthy controls for research. * Collection, linking and distribution of epidemiologic and clinical data with biospecimens. * Study-specific biospecimen and data procurement to meet the needs of individual studies, including: ** Participant identification, eligibility screening and informed consent ** Serial biospecimen procurement prior to and throughout treatment ** Study specific collection of biospecimens other than blood (buccal cells, sputum, and urine) ** Procurement and distribution of fresh biospecimens ** Collection of extended clinical and risk factor data | clinical data, epidemiologic data, cancer, control, benign cancer disease, advanced cancer, blood, serum, plasma, buffy coat, red blood cell, dna, high risk individual, healthy control, buccal cell, sputum, urine |
is listed by: One Mind Biospecimen Bank Listing has parent organization: Roswell Park Comprehensive Cancer Center |
Cancer, Control, Benign cancer, Advanced cancer, High risk individual, Healthy control | nlx_13096 | http://www.roswellpark.org/Prevention/Data_Bank_and_BioRepository | SCR_003607 | SciCrunch Registry | Roswell Park Cancer Institute DataBank and BioRepository, Roswell Park Cancer Institute Data Bank BioRepository, RPCI Data Bank BioRepository, Roswell Park Cancer Institute Data Bank and BioRepository, RPCI DataBank and BioRepository, RPCI DBBR, RPCI Data Bank and BioRepository, Roswell Park DataBank and BioRepository, Roswell Park Data Bank BioRepository | 2026-10-31 12:21:02 | 0 | ||||||
|
Nuclear Receptor Signaling Atlas Resource Report Resource Website 100+ mentions |
Nuclear Receptor Signaling Atlas (RRID:SCR_003287) | NURSA | biomaterial supply resource, material resource | THIS RESOURCE IS NO LONGER IN SERVICE.Documented on February 25, 2022.Software tool as knowledge environment resource that accrues, develops, and communicates information that advances understanding of structure, function, and role in disease of nuclear receptors (NRs) and coregulators. It specifically seeks to elucidate roles played by NRs and coregulators in metabolism and development of metabolic disorders. Includes large validated data sets, access to reagents, new findings, library of annotated prior publications in field, and journal covering reviews and techniques.As of March 20, 2020, NURSA is succeeded by the Signaling Pathways Project (SPP). | nuclear receptor, coregulator, metabolism, metabolic disorder, type 2 diabetes, obesity, osteoporosis, lipid dysregulation, cardiovascular disease, oncology, regenerative medicine, environmental agent, genomics, proteomics, reagent, ligand, microarray, gene expression, data set, data analysis service, nuclear receptor signaling, signaling, high through put screening, receptor, ligand, journal, molecule, affinity purification, q-pcr, chip-chip, animal model, antibody, cell line, primer, transcriptomine, clinical trial, disease, drug, data set |
is used by: NIF Data Federation is used by: NIDDK Information Network (dkNET) is recommended by: National Library of Medicine lists: NURSA Transcriptomine lists: STRING lists: Nuclear Receptor Cistrome is listed by: NIH Data Sharing Repositories is listed by: NIDDK Research Resources is listed by: NIDDK Information Network (dkNET) is related to: dkCOIN is related to: Integrated Manually Extracted Annotation has parent organization: Baylor College of Medicine; Houston; Texas |
Metabolic disorder, Type 2 diabetes mellitus, Obesity, Osteoporosis, Lipid dysregulation, Cardiovascular disease, Diabetes, Cancer | NHLBI ; NICHD ; NIDDK DK097748; NIEHS |
DOI:10.1101/401729 | Free, Freely available | nif-0000-03208 | https://dknet.org/about/NURSA_Archive | http://www.nursa.org | SCR_003287 | SciCrunch Registry | NURSA - Nuclear Receptor Signaling Atlas, NURSA - The Nuclear Receptor Signaling Atlas | 2026-10-31 12:21:02 | 135 |
Can't find your Tool?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. Alternatively, please register your tool with the SciCrunch Registry by adding a little information to a web form, logging in will enable users to create a provisional RRID, but it not required to submit.
Welcome to the RRID Resources search. From here you can search through a compilation of resources used by RRID and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that RRID has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on RRID then you can log in from here to get additional features in RRID such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into RRID you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
